PDUFA V
The reauthorization of the Prescription Drug User Fee Act (PDUFA V) will help advance drug development and review, ultimately helping patients access safe and effective new medicines faster. It will help drive medical innovation and economic growth by bringing greater certainty, predictability and efficiency to the FDA's drug review process.
